Range Low Price High Price Comment
30 days $2.36 $7.67 Tuesday, 30th Apr 2024 BPTH stock ended at $2.83. This is 0.702% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 5.09% from a day low at $2.71 to a day high of $2.85.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
Feb 02, 2016 $14.00 $14.00 $13.40 $13.70 2 220
Feb 01, 2016 $14.10 $14.10 $13.80 $14.10 580
Jan 29, 2016 $14.20 $14.30 $14.00 $14.00 2 620
Jan 28, 2016 $14.00 $14.20 $13.90 $14.10 3 630
Jan 27, 2016 $13.90 $14.20 $13.50 $13.90 5 900
Jan 26, 2016 $13.20 $14.00 $13.20 $13.70 4 550
Jan 25, 2016 $13.70 $14.40 $13.10 $13.10 3 250
Jan 22, 2016 $14.50 $14.60 $13.50 $13.70 8 540
Jan 21, 2016 $14.40 $14.40 $13.50 $14.20 6 140
Jan 20, 2016 $13.60 $14.20 $12.90 $13.80 11 460
Jan 19, 2016 $13.50 $14.00 $13.10 $13.40 2 940
Jan 15, 2016 $14.20 $14.20 $13.50 $13.50 8 800
Jan 14, 2016 $14.00 $14.20 $13.50 $14.10 3 740
Jan 13, 2016 $13.50 $14.40 $13.00 $14.00 8 220
Jan 12, 2016 $13.90 $13.90 $13.40 $13.40 2 540
Jan 11, 2016 $14.00 $14.00 $13.20 $13.70 3 460
Jan 08, 2016 $13.80 $14.50 $13.60 $13.80 5 250
Jan 07, 2016 $12.90 $14.00 $12.90 $13.70 7 540
Jan 06, 2016 $13.00 $13.60 $13.00 $13.30 2 280
Jan 05, 2016 $12.70 $13.50 $12.70 $13.30 3 570
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT